Quantitative PCR, using primers that target sequences in exons 26 and 27 and recognize all forms of MLCK, revealed MLCK mRNA levels are markedly decreased in bladder, colon, lung, ovary and uterine cancer tissues compared to the normal tissue (Figure 1A). Here, MYLK is linked to uterine cancer.